UCB
The HEOR & HTA Manager serves as a core member of the Pricing & Market Access Team for the Japanese market, leading HTA negotiations and CEA analysis aligned with drug pricing strategies from the clinical development phase. The role involves collaborating with global HEOR teams, internal stakeholders, and external partners to optimize ICER, create health economic evidence, and support domestic insurance reimbursement and pricing strategies. This position requires managing HEOR projects, conducting systematic reviews and meta-analyses, and contributing to policy discussions through industry activities.
Headquarters
Brussels, Brussels, Belgium
Company Size
5001-10000 employees
Founded
1928
UCB a global biopharmaceutical leader focuses on creating valuable solutions that improve the lives of people living with neurological and autoimmune conditions
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for UCB.
UCB didn’t post a salary, so this is our estimate from similar listings.